Clinical Genomics

Clinical Genomics is poised to save lives by improving the detection of Colorectal Cancer.

Thanks to revolutionary technology, we do this more effectively and more economically than the current standards of care and other emerging technologies.

Discover How

From screening to post-treatment monitoring, Clinical Genomics is by your side every step of the way – serving as your expert partner in safeguarding your health.

Get Screened.
Detect Early.
Preserve Life.

Take Control.
Monitor.
Regularly.

InSure® ONE™: An easy home-collection test for detection of blood in stool.

Learn More

COLVERA®: Blood test that monitors for recurrence by detecting circulating tumor DNA.

Learn More

The Clinical Genomics Difference

Clinical Genomics has two decades of experience striving to save lives and reduce costs by developing easy-to-use tests for use in the detection of colorectal cancer. With breakthrough diagnostic tools, the company offers affordable and accurate tests, supporting physicians and patients with potential life-saving knowledge about colorectal cancer.

Recent News & Events

Clinical Genomics Announces Expansion of Medicare Coverage of COLVERA® Liquid Biopsy for Colorectal Cancer Molecular Residual Disease and Recurrence Detection

October 5, 2021

Read Full Story Here

Clinical Genomics Announces Three Poster Presentations at ASCO 2021 Annual Meeting, Including New Data Highlighting Clinical Utility of COLVERA® Liquid Biopsy for Colorectal Cancer Recurrence Detection and Prediction of Clinical Outcomes

June 14, 2021

Read Full Story Here